Thyroid insights and innovations

Join us in advancing thyroid cancer care. The Social Butterfly blog reviews interesting research findings and increases knowledge about the field of thyroid nodule management.

Afirma® GSC Benign Results Demonstrate Real-World Utility in Outcomes Study

The Afirma Team
June 12, 2025

Read more
Confidently Rule out Thyroid Cancer in Your Clinic With an Afirma® GSC Benign Result

The Afirma Team
April 23, 2025

Read more
New Research from Veracyte Examines the Landscape of BRAF Fusions in Thyroid Tumors

Joshua Klopper, MD
April 4, 2025

Read more
The Tumor Microenvironment

Joshua Klopper, MD
February 2, 2025

Read more
New Research Presented at ATA 2024

Joshua Klopper, MD
December 17, 2024

Read more
BRAF-like vs RAS-like

Joshua Klopper, MD
October 28, 2024

Read more
Fresh FNA Sample vs. Slide Scraping

Joshua Klopper, MD
September 31, 2024

Read more
What is a Transcriptome?

Joshua Klopper, MD
August 16, 2024

Read more
New Research Presented at ENDO 2024

Joshua Klopper, MD
July 16, 2024

Read more
New Research Presented at AACE 2024

Joshua Klopper, MD
July 16, 2024

Read more
The Challenges with Repeat FNA

Joshua Klopper, MD
May 31, 2024

Read more
Assessing The Data: How Afirma Leverages Literature Reviews

Joshua Klopper, MD
April 29, 2024

Read more
The Challenge of Oncocytic (Hürthle) Cells

Joshua Klopper, MD
Jan 31, 2024

Read more
The Whole Transcriptome: A Wealth of Information

Read more
How TERT and Veracyte’s Afirma GSC Can Help Personalize Treatment Decisions in Thyroid Cancer

Joshua Klopper, MD
May 3, 2023

Read more
Recent Study Shows That, Yes, We Can Leave More Thyroids Intact

Lindsay Lipe, MS, CGC
Joshua Klopper, MD
July 27, 2022

Read more
How Does the Afirma Genomic Test Perform in the Real World?

Joshua Klopper, MD
July 27, 2022

Read more